247 assets in Acute Lymphoblastic Leukemia

Therapeutic assets addressing Acute Lymphoblastic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Peripheral Blood Stem Cells, Allogeneic, Cd34 Positive Acute Lymphoblastic Leukemia	Fred Hutchinson Cancer Center	P2/3	BBB (74)
Equine Atg Acute Lymphoblastic Leukemia	Instituto Nacional de Cancer, Brazil	P3	BBB (72)
Thioguanine Anhydrous Acute Lymphoblastic Leukemia	St. Jude Children's Research Hospital	P4	BBB (72)
Asparaginase Acute Lymphoblastic Leukemia	Centre Hospitalier Universitaire de Nice	P4	BB (71)
Cyclophosphamide Acute Lymphoblastic Leukemia	Sawa Ito, MD	P4	BB (71)
Daunomycin Acute Lymphoblastic Leukemia	PETHEMA Foundation	P4	BB (71)
Mercaptopurine Anhydrous Acute Lymphoblastic Leukemia	Dana-Farber Cancer Institute	P4	BB (71)
Methotrexate Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P4	BB (71)
Pegaspargase Acute Lymphoblastic Leukemia	Dana-Farber Cancer Institute	P4	BB (71)
Vincristine Sulfate Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	BB (71)
Adriamycin Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P4	BB (70)
Crisantaspase Acute Lymphoblastic Leukemia	Instituto do Cancer do Estado de São Paulo	P4	BB (70)
Cytarabine Acute Lymphoblastic Leukemia	Princess Maxima Center for Pediatric Oncology	P4	BB (70)
Dexasone Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P4	BB (70)
Etoposide Acute Lymphoblastic Leukemia	Memorial Sloan Kettering Cancer Center	P4	BB (70)
Fludarabine Acute Lymphoblastic Leukemia	Sawa Ito, MD	P4	BB (70)
Prednisone Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P4	BB (70)
(+)-Vincristine Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P4	BB (70)
Inotuzumab Ozogamicin Acute Lymphoblastic Leukemia	The First Affiliated Hospital of Soochow University	P4	BB (69)
Abatacept Recombinant Acute Lymphoblastic Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P3	BB (68)
Calaspargase Pegol Acute Lymphoblastic Leukemia	Children's Oncology Group	P3	BB (68)
Tucidinostat Acute Lymphoblastic Leukemia	Nanfang Hospital, Southern Medical University	P2/3	BB (68)
Hydrocortisone Acute Lymphoblastic Leukemia	Children's Oncology Group	P4	BB (67)
Idarubicin Acute Lymphoblastic Leukemia	Xianmin Song, MD	P4	BB (67)
Mitoxantrone Acute Lymphoblastic Leukemia	Tanja Andrea Gruber	P4	BB (67)
Prednisolone Acute Lymphoblastic Leukemia	Novartis Pharmaceuticals	P4	BB (67)
Rituximab Acute Lymphoblastic Leukemia	National Cancer Institute (NCI)	P4	BB (67)
Sorafenib Acute Lymphoblastic Leukemia	Nanfang Hospital, Southern Medical University	P3	BB (67)
Blinatumomab Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P3	BB (66)
Cyclosporin A Acute Lymphoblastic Leukemia	City of Hope Medical Center	P3	BB (66)
Nivestim Acute Lymphoblastic Leukemia	Guenther Koehne	P4	BB (66)
Orca-T Acute Lymphoblastic Leukemia	Stanford University	P3	BB (66)
Pembrolizumab Acute Lymphoblastic Leukemia	OHSU Knight Cancer Institute	P2	BB (66)
Erwinia L-Asparaginase Acute Lymphoblastic Leukemia	Pfizer	P3	BB (65)
Imatinib Acute Lymphoblastic Leukemia	PETHEMA Foundation	P4	BB (65)
Tacrolimus Acute Lymphoblastic Leukemia	Memorial Sloan Kettering Cancer Center	P3	BB (65)
Alemtuzumab Acute Lymphoblastic Leukemia	University of Birmingham	P2/3	BB (64)
Basiliximab Acute Lymphoblastic Leukemia	City of Hope Medical Center	P2	BB (64)
Thiotepa Acute Lymphoblastic Leukemia	Sawa Ito, MD	P3	BB (64)
Busulfanum Acute Lymphoblastic Leukemia	Sawa Ito, MD	P4	B (63)
cd19-ucart Acute Lymphoblastic Leukemia	Zhujiang Hospital	P2	B (63)
Sirolimus Acute Lymphoblastic Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P3	B (63)
18f-flt Acute Lymphoblastic Leukemia	University of Oklahoma	P2	B (62)
Allopurinol Acute Lymphoblastic Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Acute Lymphoblastic Leukemia	The First Affiliated Hospital of Soochow University	P3	B (62)
Bortezomib Acute Lymphoblastic Leukemia	Instituto do Cancer do Estado de São Paulo	P4	B (62)
Dasatinib Acute Lymphoblastic Leukemia	Nanfang Hospital, Southern Medical University	P3	B (62)
Humax-Cd20 Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	B (62)
Isocyclophosphamide Acute Lymphoblastic Leukemia	Ho Joon Im	P3	B (62)
Melphalan Acute Lymphoblastic Leukemia	Guenther Koehne	P3	B (62)

Showing 1 to 50 of 247 assets

PreviousPage 1 of 5Next